Psymed Ventures is a venture capital fund that invests in cutting-edge technologies to advance mental health and wellness. The fund provides capital and support to innovative companies that prioritize healing, responsibility, and profitability. Psymed Ventures is investing in new categories to revolutionize mental health treatment, such as precision psychiatry, drug development platforms, novel ketamine formulations, combination therapies, next generation psychedelics, and bioelectronic solutions. The fund is also donating 4.19% of its profits to psychedelic non-profits and individuals. What sets Psymed Ventures apart from other businesses in the same industry is its commitment to the community, its focus on healing, responsibility, and profitability, and its dedication to advancing mental health and wellness through cutting-edge technologies.